Inventor · disambiguated record
Jeffrey J. Hale
Also filed as: HALE JEFFREY · HALE JEFFREY J · HALE JEFFREY JOHN
42 granted patents·14 pending applications·1,371 citations·filing 1992–2025
98Inventor score
Files withMERCK & CO INC31MERCK SHARP & DOHME5CLEMENTS MATTHEW J3NESTED THERAPEUTICS INC3COLANDREA VINCENT J2
Top patents by PatentIndex Score
56 records- 0199US5719147AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Feb 17, 1998·193 cites·27 claims
- 0296US6166037APyrrolidine and piperidine modulators of chemokine receptor activityMERCK & CO INC·Filed 1998·Granted Dec 26, 2000·171 cites·25 claims
- 0396US5691336AMorpholine compounds are prodrugs useful as tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Nov 25, 1997·154 cites·25 claims
- 0494US5750549ACycloalkyl tachykinin receptor antagonistsMERCK & CO INC·Filed 1996·Granted May 12, 1998·89 cites·30 claims
- 0594US5637699AProcess for preparing morpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Jun 10, 1997·85 cites·2 claims
- 0693US5877191APhenyl spiroethercycloalkyl tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Mar 2, 1999·71 cites·16 claims
- 0792US8354403B2Pyrrolidine derived beta 3 adrenergic receptor agonistsMERCK SHARP & DOHME·Filed 2010·Granted Jan 15, 2013·15 cites·14 claims
- 0890US7351725B2N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonistsMERCK & CO INC·Filed 2003·Granted Apr 1, 2008·40 cites·10 claims
- 0990US6248755B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Jun 19, 2001·52 cites·39 claims
- 1088US7999107B2Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulatorsMERCK SHARP & DOHME·Filed 2008·Granted Aug 16, 2011·13 cites·16 claims
- 1188US6399619B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Jun 4, 2002·23 cites·28 claims
- 1288US5780467AMorpholine compounds are prodrugs useful as tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Jul 14, 1998·60 cites·19 claims
- 1387US7309721B2Aminoalkylphosphonates and related compounds as Edg receptor agonistsMERCK & CO INC·Filed 2003·Granted Dec 18, 2007·37 cites·15 claims
- 1486US7479504B2Edg receptor agonistsMERCK & CO INC·Filed 2003·Granted Jan 20, 2009·28 cites·5 claims
- 1586US6235735B1Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2000·Granted May 22, 2001·19 cites·18 claims
- 1685US7906652B2Heterocycle-substituted 3-alkyl azetidine derivativesMERCK SHARP & DOHME·Filed 2006·Granted Mar 15, 2011·8 cites·9 claims
- 1783US8372863B2Tetrahydro-1H-pyrrolo fused pyridonesMERCK SHARP & DOHME·Filed 2009·Granted Feb 12, 2013·4 cites·14 claims
- 1883US7605171B2(3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonistsMERCK & CO INC·Filed 2004·Granted Oct 20, 2009·27 cites·15 claims
- 1983US7220734B21-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonistsMERCK & CO INC·Filed 2003·Granted May 22, 2007·19 cites·17 claims
- 2082US7199142B21-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonistsMERCK & CO INC·Filed 2003·Granted Apr 3, 2007·21 cites·12 claims
- 2182US5512570ATreatment of emesis with morpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Apr 30, 1996·43 cites·15 claims
- 2280US6265434B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Jul 24, 2001·17 cites·36 claims
- 2380US5716942ATreatment of migraine with morpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1995·Granted Feb 10, 1998·39 cites·20 claims
- 2479US6498161B1Pyrrolidine modulators of chemokine receptor activityMERCK & CO INC·Filed 2000·Granted Dec 24, 2002·12 cites·43 claims
- 2577US5869496ASpiro-substituted azacycles as tachykinin receptor antagonistsMERCK & CO INC·Filed 1994·Granted Feb 9, 1999·37 cites·16 claims
- 2677US5591737ASubstituted azetidinones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1993·Granted Jan 7, 1997·18 cites·31 claims
- 2774US5872116AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Feb 16, 1999·14 cites·21 claims
- 2872US6048859AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1999·Granted Apr 11, 2000·26 cites·23 claims
- 2971US8492398B2SpiroazaindolesPIERCE NEE FLETCHER JOAN M·Filed 2009·Granted Jul 23, 2013·3 cites·15 claims
- 3071US8445680B2Tetrahydrothieno pyridinesDEBENHAM JOHN S·Filed 2009·Granted May 21, 2013·2 cites·14 claims
- 3171US6638930B2Morpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 2001·Granted Oct 28, 2003·1 cites·4 claims
- 3264US2025120961A1P53 modulatorsNESTED THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3363US8815865B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2010·Granted Aug 26, 2014·1 cites·4 claims
- 3461US2025289811A1Heterocyclic derivatives as mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3560US9365539B2Prolylcarboxypeptidase inhibitorsHALE JEFFREY J·Filed 2011·Granted Jun 14, 2016·1 cites·9 claims
- 3660US7125887B2Pyrrolidine modulators of CCR5 chemokine receptor activityMERCK & CO INC·Filed 2001·Granted Oct 24, 2006·1 cites·27 claims
- 3760US5922706AMorpholine and thiomorpholine tachykinin receptor antagonistsMERCK & CO INC·Filed 1997·Granted Jul 13, 1999·6 cites·21 claims
- 3859US5747485ASubstituted azetidiones as anti-inflammatory and antidegenerative agentsMERCK & CO INC·Filed 1997·Granted May 5, 1998·20 cites·10 claims
- 3956US8921555B2Substituted-1,3,8-triazaspiro[4.5]decane-2,4-dionesPIERCE JOAN M·Filed 2010·Granted Dec 30, 2014·1 cites·4 claims
- 4055US2007224263A1Aminoalkylphosphonates and related compounds as Edg receptor agonistsDOHERTY GEORGE A·Filed 2007·Application pending·0 cites
- 4150US2005107345A1Aminoalkylphosphonates and related compounds as edg receptor agonistsFiled 2003·Application pending·0 cites
- 4246US8278304B2Substituted 4-hydroxypyrimidine-5-carboxamidesCLEMENTS MATTHEW J·Filed 2009·Granted Oct 2, 2012·0 cites·17 claims
- 4346US2010056563A1Novel 1.8-naphthyridine compoundsGUIADEEN DEODIALSINGH·Filed 2008·Application pending·0 cites
- 4445US2004058894A1Selective S1P1/Edg1 receptor agonistsFiled 2003·Application pending·0 cites
- 4545US2005070506A1Selective s1p1/edg1 receptor agonistsFiled 2003·Application pending·0 cites
- 4644US7659294B22-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonistsMERCK & CO INC·Filed 2005·Granted Feb 9, 2010·0 cites·11 claims
- 4744US2010029697A1Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulatorsDEBENHAM JOHN S·Filed 2008·Application pending·0 cites
- 4844US2025288571A1Mitogen-activated protein kinase (mek) inhibitorsNESTED THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4943US2007043014A13,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonistsMERCK & CO INC·Filed 2004·Application pending·0 cites
- 5040US2012135975A1Substituted Esters as Cannabinoid-1 Receptor ModulatorsCOLANDREA VINCENT J·Filed 2007·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →